biomedcentral.com/bmcpharmacol/article
Bottom,Top,Right1
  • Welcome Stanford University
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
BMC Pharmacology
Search for
Advanced search
  • Home
  • Articles

Advertisement

Articles

  • All articles RSS
  • Most viewed RSS
  • Archive
  • Supplements
Supplements
Please provide a volume number.

Page 1 of 8

1 2 3 4 5 6 7 8  Next

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

Research article   Open Access Highly Accessed

Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio

Somayeh Jafari, Marc E Bouillon, Xu-Feng Huang, Stephen G Pyne, Francesca Fernandez-Enright BMC Pharmacology 2012, 12:8 (22 June 2012)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation

Niina Aaltonen, Marko Lehtonen, Katri Varonen, Gemma Goterris, Jarmo T Laitinen BMC Pharmacology 2012, 12:7 (11 June 2012)

Abstract | Full text | PDF | PubMed

Research article   Open Access

The orthosteric agonist 2-chloro-5-hydroxyphenylglycine activates mGluR5 and mGluR1 with similar efficacy and potency

Paul J Kammermeier BMC Pharmacology 2012, 12:6 (29 May 2012)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity

Thomas A Munro, Loren M Berry, Ashlee Van’t Veer, Cécile Béguin, F Carroll, Zhiyang Zhao, William A Carlezon, Bruce M Cohen BMC Pharmacology 2012, 12:5 (29 May 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Plasma levels of kappa opioid antagonists in mice following intraperitoneal administration show a strong negative correlation with the prolonged time-course of antagonism, consistent with an irreversible mechanism of action such as receptor desensitisation.

Research article   Open Access

5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved

Robert Davis, Jill Pattison, Janice M Thompson, Ruslan Tiniakov, Karie E Scrogin, Stephanie W Watts BMC Pharmacology 2012, 12:4 (6 May 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Chronic infusion with 5-hydroxytryptamine (5-HT) reduces total peripheral resistance, and this effect is not due to direct arterial mesenteric relaxation since 5-HT receptors present in the superior mesenteric artery are not functional.

Research article   Open Access Highly Accessed

Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors

John Cuppoletti, Anthony T Blikslager, Jayati Chakrabarti, Prashant K Nighot, Danuta H Malinowska BMC Pharmacology 2012, 12:3 (3 May 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Comparison of linaclotide with lubiprostone in experimental models of epithelial barrier function and repair suggests that patients with compromised barrier function, such as in irritable bowel syndrome may benefit more from treatment with lubiprostone.

Research article   Open Access Highly Accessed

Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor

Aiying Wang, Charles Dorso, Lisa Kopcho, Gregory Locke, Robert Langish, Eric Harstad, Petia Shipkova, Jovita Marcinkeviciene, Lawrence Hamann, Mark S Kirby BMC Pharmacology 2012, 12:2 (4 April 2012)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Computational models for in-vitro anti-tubercular activity of molecules based on high-throughput chemical biology screening datasets

Vinita Periwal, Shireesha Kishtapuram, Open Source Drug Discovery Consortium, Vinod Scaria BMC Pharmacology 2012, 12:1 (31 March 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Computational methods based on Machine Learning tools and supervised classifiers generate accurate predictive models for virtual high-throughput screens of large libraries of anti-tubercular molecules, allowing prioritization of good candidates for drug discovery.

Research article   Open Access Highly Accessed

The effect of formulation vehicles on the in vitro percutaneous permeation of ibuprofen

Jessica Stahl, Mareike Wohlert, Manfred Kietzmann BMC Pharmacology 2011, 11:12 (14 December 2011)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Polyamidoamine (PAMAM) dendrimer conjugate specifically activates the A3 adenosine receptor to improve post-ischemic/reperfusion function in isolated mouse hearts

Tina C Wan, Dilip K Tosh, Lili Du, Elizabeth T Gizewski, Kenneth A Jacobson, John A Auchampach BMC Pharmacology 2011, 11:11 (31 October 2011)

Abstract | Full text | PDF | PubMed |  Editor’s summary

A Polyamidoamine (PAMAM) dendrimer conjugated to 64 moieties of a nucleoside agonist binds to the mouse A3 adenosine receptor with enhanced potency and selectivity, and mediates cardioprotective effects in an isolated heart model of ischemia/reperfusion injury.

Research article   Open Access Highly Accessed

Protection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in mice

Elizabeth Chia, Satomi Kagota, Enoka P Wijekoon, John J McGuire BMC Pharmacology 2011, 11:10 (28 September 2011)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Vasodilatation mediated by protease-activated receptor 2 (PAR2) is retained in a mouse model of Angiotensin-II induced hypertension and mesenteric arterial vascular dysfunction, through a mechanism dependent on the calcium-activated potassium channel SK3.1.

Research article   Open Access

Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors

Jacob D Durrant, J Andrew McCammon BMC Pharmacology 2011, 11:9 (30 August 2011)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages

Linda Palma, Carla Sfara, Antonella Antonelli, Mauro Magnani BMC Pharmacology 2011, 11:8 (26 July 2011)

Abstract | Full text | PDF | PubMed |  Editor’s summary

The glucocorticoid analogue dexamethasone reduces the expression of interleukin-23p19 in human monocyte-derived macrophages via a distinct cascade of down-modulation, secondary to the suppression of p38 MAPK activity and likely involving MAPK phosphatase-1 (MKP-1).

Research article   Open Access Highly Accessed

Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells

Elizabeth Alli, Vandana B Sharma, Anne-Renee Hartman, Patrick S Lin, Lisa McPherson, James M Ford BMC Pharmacology 2011, 11:7 (19 July 2011)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors

Tamaki Hayase BMC Pharmacology 2011, 11:6 (18 July 2011)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

A web server for predicting inhibitors against bacterial target GlmU protein

Deepak Singla, Meenakshi Anurag, Debasis Dash, Gajendra PS Raghava BMC Pharmacology 2011, 11:5 (6 July 2011)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

A Quantitative Structure Activity Relationship (QSAR) model based on docking energy descriptors predicts potential inhibitors of the Mycobacterium tuberculosis drug target GlmU, that could be used in the development of drugs against tuberculosis.

Research article   Open Access Highly Accessed

Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo

Chieko Kudo, Hiroyuki Yamakoshi, Atsuko Sato, Hiroshi Nanjo, Hisatsugu Ohori, Chikashi Ishioka, Yoshiharu Iwabuchi, Hiroyuki Shibata BMC Pharmacology 2011, 11:4 (28 May 2011)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Synthetic analogs of natural curcumin, found in the popular Indian spice turmeric, overcome the compound's low bioavailability and display enhanced chemotherapeutic potential both in vitro and in a mouse model of colorectal carcinogenesis.

Research article   Open Access Highly Accessed

Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice

Pablo R Moya, Meredith A Fox, Catherine L Jensen, Justin L Laporte, Helen T French, Jens R Wendland, Dennis L Murphy BMC Pharmacology 2011, 11:3 (7 April 2011)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Knock-out mice for the serotonin transporter (SERT) are impaired in the anxiogenic response induced by serotonin receptor agonists and display an increased editing of the serotonin 5-HT2C receptor RNA compared to wild-type.

Research article   Open Access Highly Accessed

Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro

W Dimpfel, JA Hoffmann BMC Pharmacology 2011, 11:2 (21 February 2011)

Abstract | Full text | PDF | PubMed |  Editor’s summary

The new Parkinson`s disease drug rasagiline and its metabolite aminoindan, affect the glutamate receptor mediated signaling pathway and display dose-dependent neuroprotective activity in the rat hippocampus.

Research article   Open Access Highly Accessed

The boron-oxygen core of borinate esters is responsible for the store-operated calcium entry potentiation ability

Olivier Dellis, Pierre Mercier, Christine Chomienne BMC Pharmacology 2011, 11:1 (26 January 2011)

Abstract | Full text | PDF | PubMed |  Editor’s summary

The Boron-oxygen core present in 2-aminoethyl diphenylborinate (2-APB) and other borinate ester analogues is required for the dual potentiation and inhibition of Store-Operated Calcium Entry (SOCE) in leukocyte cell lines.

Research article   Open Access Highly Accessed

Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study

Idrian García-García, Carlos A González-Delgado, Carmen M Valenzuela-Silva, Alina Díaz-Machado, Marisol Cruz-Díaz, Hugo Nodarse-Cuní, Orlando Pérez-Pérez, Cimara H Bermúdez-Badell, Joel Ferrero-Bibilonia, Rolando Páez-Meireles, Iraldo Bello-Rivero, Fidel R Castro-Odio, Pedro A López-Saura, for the FarmaPEG Study Group BMC Pharmacology 2010, 10:15 (23 November 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article   Open Access Highly Accessed

Histopathology and biochemistry analysis of the interaction between sunitinib and paracetamol in mice

Adeline YL Lim, Ignacio Segarra, Srikumar Chakravarthi, Sufyan Akram, John P Judson BMC Pharmacology 2010, 10:14 (15 October 2010)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Protective efficacy of natansnin, a dibenzoyl glycoside from Salvinia natans against CCl4 induced oxidative stress and cellular degeneration in rat liver

Polimetla Srilaxmi, Gangadhara Sareddy, Polavarapu kishor, Oruganti Setty, Phanithi Babu BMC Pharmacology 2010, 10:13 (12 October 2010)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells

Leilei Tang, Saskia M Bergevoet, Christian Gilissen, Theo de Witte, Joop H Jansen, Bert A van der Reijden, Reinier AP Raymakers BMC Pharmacology 2010, 10:12 (13 September 2010)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia

Che-Chuan Wang, Chung-Ching Chio, Ching-Hong Chang, Jinn-Rung Kuo, Ching-Ping Chang BMC Pharmacology 2010, 10:11 (6 September 2010)

Abstract | Full text | PDF | PubMed

Page 1 of 8

1 2 3 4 5 6 7 8  Next


  • Terms and Conditions

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.